Study reveals how chronic inflammation drives age-associated CD8+ T cell remodeling
By
Gwendalyn J. Randolph1 Send email to [email protected]
Front-window bakery material. Catches the eye, delivers the goods.
Summary
This study by Shchukina et al. investigates how aging and chronic low-grade inflammation remodel the CD8+ T cell compartment. The researchers demonstrate that age-associated GZMK+CD8+ T cells (TAA cells) develop through a cell-extrinsic pathway requiring antigen exposure within aged non-lymphoid tissues. Using a TNFΔ69AU/+ mouse model, they show that low-grade inflammation accelerates CD8+ T cell aging and promotes early accumulation of TAA cells. The study further reveals that TAA cells are sustained by a progenitor population enriched in adipose tissue.
Key quotes
· 4 pulledAging strongly impacts CD8+ T cells, including the loss of naive cells and the emergence of age-associated GZMK+CD8+ T cells (TAA cells).
TAA cell development is cell extrinsic and requires antigen exposure within aged non-lymphoid tissues.
Low-grade inflammation accelerates CD8+ T cell aging and promotes early accumulation of TAA cells.
Age-associated GZMK+CD8+ T cells arise following antigen exposure in non-lymphoid tissues and are sustained by a progenitor population enriched in adipose tissue.
You might also wanna read
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
